The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Started
2023-08-01
Last updated
2024-10-15
Condition(s) studied
Prostate CancerProstate Disease
Study summary
hrDWI might be an alternative to cDWI for the prostate imaging.
1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general
2. improve the diagnostic accuracy of PCa in particular than conventional DWI
Eligibility
Sex
MALE
Min age
55 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps;
2. Complete clinical information.
Exclusion Criteria:
Men were excluded if they were using 5-alpha-reductase inhibitors at time of examination or has used such during the previous six months; or if they had a previous history of prostatic biopsy, prostatic surgery, or treatment for PCa
Primary outcome measure(s)
image quality evaluation — 2024.01-2025.12 objective and subjective image quality and lesion conspicuity
Trial sites (2)
Facility
City
Region
Status
The First Affiliated Hospital with Nanjing Medical University
Nanjing
Jiangsu
Recruiting
Yu-Dong Zhang
Nanjing
China
Recruiting
More The First Affiliated Hospital with Nanjing Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.